Maze Therapeutics (MAZE) EBITDA (2024 - 2026)
Maze Therapeutics' (MAZE) quarterly EBITDA came in at -$26.6 million in Q1 2026, up 24.99% year-on-year from -$21.2 million in Q1 2025, and up 30.23% quarter-over-quarter from -$38.1 million in Q4 2025.
Maze Therapeutics (MAZE) EBITDA (2024 - 2026) Analysis & Trends
Maze Therapeutics has disclosed EBITDA across 3 years of filings, most recently posting -$26.6 million for Q1 2026.
- EBITDA for Q1 2026 came in at -$26.6 million, up 24.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$134.1 million (down 3601.85% YoY), and the FY2025 annual result was -$142.9 million, down 1374.18% from the prior year.
- EBITDA came in at -$26.6 million for Q1 2026 at Maze Therapeutics, up from -$38.1 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $139.6 million in Q2 2024 to a low of -$76.1 million in Q4 2024.
- The 3-year median for EBITDA is -$33.0 million (2025), against an average of -$17.6 million.
- Peak annual rise in EBITDA reached 49.99% in 2025, while the deepest fall reached 126.14% in 2025.
- Maze Therapeutics' EBITDA stood at -$76.1 million in 2024, then soared by 49.99% to -$38.1 million in 2025, then jumped by 30.23% to -$26.6 million in 2026.
- The last three EBITDA figures came in at -$26.6 million (Q1 2026), -$38.1 million (Q4 2025), and -$33.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Maze Therapeutics | 1.31 Bn | 1.31 Bn | 18.21 Mn | -26.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.55 Mn |
| Dec 31, 2025 | -38.06 Mn |
| Sep 30, 2025 | -32.97 Mn |
| Jun 30, 2025 | -36.47 Mn |
| Mar 31, 2025 | -35.40 Mn |
| Dec 31, 2024 | -76.10 Mn |
| Sep 30, 2024 | -24.23 Mn |
| Jun 30, 2024 | 139.56 Mn |
| Mar 31, 2024 | -28.01 Mn |